KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Acquisitions (2017 - 2023)

Historic Acquisitions for Exact Sciences (EXAS) over the last 6 years, with Q4 2023 value amounting to $2.4 million.

  • Exact Sciences' Acquisitions fell 8430.16% to $2.4 million in Q4 2023 from the same period last year, while for Dec 2024 it was $67.8 million, marking a year-over-year increase of 206.28%. This contributed to the annual value of $52.4 million for FY2023, which is 25689.09% up from last year.
  • According to the latest figures from Q4 2023, Exact Sciences' Acquisitions is $2.4 million, which was down 8430.16% from $50.0 million recorded in Q3 2023.
  • In the past 5 years, Exact Sciences' Acquisitions registered a high of $973.9 million during Q4 2019, and its lowest value of -$1.4 million during Q3 2022.
  • Moreover, its 5-year median value for Acquisitions was $11.1 million (2020), whereas its average is $128.9 million.
  • Its Acquisitions has fluctuated over the past 5 years, first skyrocketed by 4735555.56% in 2021, then tumbled by 9905.26% in 2022.
  • Over the past 5 years, Exact Sciences' Acquisitions (Quarter) stood at $973.9 million in 2019, then tumbled by 100.0% to $4000.0 in 2020, then surged by 2104425.0% to $84.2 million in 2021, then tumbled by 81.74% to $15.4 million in 2022, then crashed by 84.3% to $2.4 million in 2023.
  • Its Acquisitions stands at $2.4 million for Q4 2023, versus $50.0 million for Q3 2023 and $15.4 million for Q4 2022.